Actilyse
DrugActilyse is the intra-venous agent used for intra-venous thrombolysis in the acute phase of cerebral infarction.
Other names: rtPA
NCT Number: NCT03451903
This study aims to identify factors influencing the time span and success of reperfusion after a mechanical thrombectomy in the acute phase of cerebral infarction, and in particular the effect of intra-venous thrombolysis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Mechanical thrombectomy (MT), associated with standard IV thrombolysis (IVT) treatment, is effective during the acute phase of cerebral infarction with proximal occlusion of the anterior circulation in reducing disability at three months. MT-only treatment has only been assessed retrospectively in subgroups of controlled studies, with a significant difference in favour of the treatment. These results have led to a discussion about the benefits of MT without IVT in cases of proximal occlusion or carotid terminus occlusion. Recent data are in favour of a better prognosis for patients benefiting from a combined procedure. The impact of IVT on the implementation of MT is widely disputed, in particular the speed of execution, which could be enhanced by IVT. The factors influencing the time span and success of reperfusion after an MT are still not well-known, IVT in particular. The investigators have made the assumption that IVT could have an effect on the success of MT by shortening the duration of the procedure and increasing the likelihood of satisfactory revascularisation.
The investigators carried out a retrospective study based on data gathered prospectively by the Franche-Comté Stroke Registry. The investigators also considered other factors which could have affected the duration of the procedure or the rate of satisfactory revascularisation, including location of infarct, thrombus size and stroke aetiology.
Hypothesis: the investigators have made the assumption that IVT could have an effect on the success of MT by shortening the duration of the procedure and increasing the likelihood of satisfactory revascularisation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Actilyse is the intra-venous agent used for intra-venous thrombolysis in the acute phase of cerebral infarction.
Other names: rtPA
Mechanical thrombectomy is an endovascular procedure by which an arterial clot is retrieved, in order to reperfuse the brain.
Time frame: From the beginning of mechanical thrombectomy to the end of the procedure.
It is the period of time between when the artery is punctured and when the first image from the first cerebral angiographic test is acquired after revascularisation, which is used to calculate the rate of revascularisation.
Centre Hospitalier Universitaire de Besancon
Other
Acronym: REPAIR-FC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02368145
Acute Stroke, Brain Diseases
New Brunswick, New Jersey, United States
View Trial DetailsNCT07295366
Acute Stroke, Arterial Occlusive Diseases
Xuzhou, Jiangsu, China
View Trial DetailsNCT02900833
Acute Stroke, Brain Diseases
Paris, France
View Trial DetailsNCT05998902
Acute Stroke, Brain Diseases
Chongqing, Chongqing Municipality, China
View Trial Details